Stock Symbol:

PDLI

Company Name:

PDL BioPharma, Inc.

Company Description:

PDL BioPharma, Inc. engages in the management of antibody humanization patents and royalty assets, which consist of its Queen et al. patents and license agreements with various biotechnology and pharmaceutical companies.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

J-A-J-O

Stock Exchange:

NASDAQ

Predicted Split Price:

$44.00

Predicted Split Ratio:

2 for 1

5 Day Performance After Split:

3.7%

Prior Stock Splits:

2

Stock Split History:

23-Aug-00 [2:1], 10-Oct-01 [2:1]

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.